Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.
35th Annual Meeting of the Asian Pacific Association for the Study of the Liver (APASL 2026)
Presentation schedule and materials
Friday, 24 April 2026
19:20
TRT
2347
ORAL PRESENTATION
Semaglutide demonstrates efficacy in improving liver fibrosis across diverse subpopulations in part 1 of the ESSENCE trial outcomes in Asian and non-Asian populations
Jacob George 1; Atsushi Nakajima 2; Chun-Jen Liu 3; Won Kim 4; George Boon Bee Goh 5; Jidong Jia 6; Kwabena Opuni 7; Niels Krarup 7; Mette Skalshøi Kjær 7; Anna Maria Bartyzel 7 & Arun J. Sanyal 8.